| Metric | FY 2024 | Prior Q | FY 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $2.4B | — | $2.2B | — | 8.7% |
| Op. Income | $184M | — | $134M | — | 37.4% |
| Gross Margin | 34.9% | — | 33.7% | — | 1.3pp |
| Net Margin | 6.0% | — | 4.6% | — | 1.4pp |
| EPS (Diluted) | $7.77 | — | $5.53 | — | 40.5% |
| Free Cash Flow | $135M | — | $44M | — | 208.1% |
| Item | Amount |
|---|---|
| REVENUE | $2.4B |
| Cost of Revenue | $1.6B |
| GROSS PROFIT | $848M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $523M |
| Other Expenses | $141M |
| Operating Expenses | $664M |
| Cost & Expenses | $2.2B |
| OPERATING INCOME | $184M |
| Interest Income | $7M |
| Interest Expense | $0 |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $189M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $145M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $145M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $145M |
| D&A | $141M |
| EBIT | $184M |
| EBITDA | $325M |
| EPS | $8 |
| EPS Diluted | $8 |
| Item | Amount |
|---|---|
| REVENUE | $2.4B |
| Cost of Revenue | $1.6B |
| GROSS PROFIT | $848M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $523M |
| Other Expenses | $141M |
| Operating Expenses | $664M |
| Cost & Expenses | $2.2B |
| OPERATING INCOME | $184M |
| Interest Income | $7M |
| Interest Expense | $0 |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $189M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $145M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $145M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $145M |
| D&A | $141M |
| EBIT | $184M |
| EBITDA | $325M |
| EPS | $8 |
| EPS Diluted | $8 |
| Item | Amount |
|---|---|
| Net Income | $145M |
| Depreciation & Amortization | $141M |
| Stock-Based Compensation | $10M |
| Deferred Income Tax | $5M |
| Other Non-Cash Items | $3M |
| Change in Working Capital | -$10M |
| OPERATING CASH FLOW | $295M |
| Capital Expenditure | -$160M |
| Acquisitions (Net) | -$203.0K |
| Purchases of Investments | -$25M |
| Sales/Maturities of Investments | $22M |
| Other Investing Activities | $1M |
| NET CASH FROM INVESTING | -$162M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$24M |
| Common Dividends Paid | -$23M |
| Other Financing Activities | -$3M |
| NET CASH FROM FINANCING | -$50M |
| FREE CASH FLOW | $135M |
| Net Change in Cash | $82M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $162M |
| Short-Term Investments | $14M |
| Net Receivables | $279M |
| Inventory | $395M |
| Other Current Assets | $52M |
| TOTAL CURRENT ASSETS | $916M |
| PP&E (Net) | $868M |
| Goodwill | $649M |
| Intangible Assets | $120M |
| Long-Term Investments | $0 |
| Tax Assets | $833.0K |
| Other Non-Current Assets | $143M |
| TOTAL NON-CURRENT ASSETS | $1.8B |
| TOTAL ASSETS | $2.7B |
| Account Payables | $93M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $281M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $256M |
| TOTAL NON-CURRENT LIABILITIES | $306M |
| TOTAL LIABILITIES | $588M |
| Common Stock | $2M |
| Additional Paid-In Capital | $105M |
| Retained Earnings | $2.0B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$24M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.1B |
| TOTAL LIABILITIES & EQUITY | $2.7B |
| Total Debt | $69M |
| Net Debt | -$93M |
